Overview

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
Phase:
Phase 1
Details
Lead Sponsor:
POZEN
Treatments:
Aspirin
Celecoxib